
Bioactive Heterocyclic Compound Classes. 2 Volume Set
Kurzinformation



inkl. MwSt. Versandinformationen
Artikel zZt. nicht lieferbar
Artikel zZt. nicht lieferbar

Beschreibung
Bioactive Heterocyclic Compound Classes. 2 Volume Set von Lamberth, Clemens
Produktdetails

So garantieren wir Dir zu jeder Zeit Premiumqualität.
Über den Autor
Clemens Lamberth is a senior team leader in the crop protection research department of Syngenta AG, Switzerland. He studied chemistry at the Technical University of Darmstadt, Germany, where he obtained his Ph.D. under the supervision of Prof. Bernd Giese in 1990. Subsequently, he spent one and a half years as a postdoctoral fellow in the group of Prof. Mark Bednarski at the University of California at Berkeley (USA). In 1992 Clemens Lamberth joined the agrochemical research department of Sandoz Agro AG, Switzerland, which is today, after two mergers, part of Syngenta Crop Protection AG. Since 20 years he is specialized in fungicide discovery. He was the organizer of the two-day session "New Trends for Agrochemicals" at the 2nd EUCHEMS congress in Torino, Italy, 2008. He is the author of 46 publications and 56 patents and the inventor of Syngenta's fungicide mandipropamid (Revus®, Pergado®). Jürgen Dinges obtained his M.S. degree in organic chemistry at the Technical University in Darmstadt, Germany, in 1988. He then joined the group of Prof. Frieder W. Lichtenthaler at the same university, where he received his Ph.D. degree in organic chemistry and chemical engineering in 1991. After being awarded a Feodor-Lynen scholarship from the Humboldt foundation, he spent 18 months as a postdoctoral fellow in the group of Prof. William G. Dauben at the University of California at Berkeley (USA). In 1993, Jürgen Dinges joined the department for biochemistry at Syntex, USA and since 1995 he is working in the pharmaceutical research department at Abbott Laboratories, USA. During his 18 years of industrial experience, Jürgen Dinges has specialized in drug discovery. In 2009, he was a guest editor for "Current Topics in Medicinal Chemistry" for a special issue on Parkinson's disease. He is an author of 17 publications and 23 patents and a co-inventor of more than 10 clinical drug development candidates.
- Gebunden
- 637 Seiten
- Erschienen 2011
- Wiley-VCH
- hardcover
- 2446 Seiten
- Erschienen 2011
- Wiley-VCH
- Hardcover
- 508 Seiten
- Erschienen 1988
- Springer
- paperback
- 398 Seiten
- Erschienen 2008
- Elsevier Science
- Kartoniert
- 746 Seiten
- Erschienen 2011
- Wiley-VCH
- Hardcover -
- -
- hardcover
- 871 Seiten
- Erschienen 2005
- Wiley-VCH
- Hardcover -
- Erschienen 2004
- Wiley-VCH
- Hardcover
- 442 Seiten
- Erschienen 2023
- Wiley
- Kartoniert
- 639 Seiten
- Erschienen 2003
- Wiley-VCH
- hardcover
- 689 Seiten
- Erschienen 2007
- Wiley-VCH
- Gebunden
- 583 Seiten
- Erschienen 2010
- Wiley-VCH